Tag: US54303L1044

Longeveron Announces Full-Year 2024 Financial Results and Provides Business Update

Pivotal Phase 2b clinical trial (ELPIS II) evaluating Lomecel-B™ (laromestrocel) in Hypoplastic Left…

GlobeNews Wire GlobeNews Wire